Dietrich, Eva Susanne; Schubert, Bjorn; Ebner, Winfried; … - In: PharmacoEconomics 19 (2001) 1, pp. 79-94
Objective: To compare the cost, efficacy and cost efficacy of tazobactam/ piperacillin and imipenem/cilastatin in the …/day) and imipenem/cilastatin (total daily dosage of 1.5 to 4 g/day). The mean duration of treatment varied from 5.5 to 8.2 days … for tazobactam/piperacillin and 5 to 9.4 days for imipenem/cilastatin. Main outcome measure and results: Compared with …